Comparative study – in vitro
A comparative study performed by RISE (Research Institutes of Sweden) to be published confirms the benefits of using LuerJack. When comparing a conventional syringe with a safety needle vs. LuerJack with a conventional needle, LuerJack reduces the risk of cross-contamination by 46% and the risk of a needlestick injury by 50%.
Click on below video to watch a summary of our clinical evidence
Click on below link to access the clinical evidence brochure presented above
Brochure – MaM-20170517-3 Clinical Evidence summary